Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
closed
CV Therapeutics
News
Astellas May Abandon Chase for CV Therapeutics, Analysts Say
Bloomberg
Astellas
buyouts
CV Therapeutics
Gilead Sciences
»
Login
or
register
to post comments
News
Gilead pulls CV Therapeutics from jaws of Astellas
Yahoo/Reuters
Astellas
buyouts
CV Therapeutics
Gilead Sciences
»
Login
or
register
to post comments
News
Astellas Seeks to Oust CV Therapeutics Board in Takeover Bid
Bloomberg
Astellas
buyouts
CV Therapeutics
hostile takeover
»
Login
or
register
to post comments
News
Astellas sues CV Therapeutics over rights plan
Yahoo
Astellas
CV Therapeutics
»
Login
or
register
to post comments
News
Astellas Files Lawsuit against CV Therapeutics
Yahoo
Astellas
CV Therapeutics
lawsuits
»
Login
or
register
to post comments
News
Astellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in Cash
Businesswire
Astellas
buyouts
CV Therapeutics
»
Login
or
register
to post comments
News
CV Therapeutics To Astellas: No Thanks
Forbes
Astellas
buyouts
CV Therapeutics
»
Login
or
register
to post comments
News
Astellas Pharma to continue pursuing buyout of CV Therapeutics following latest rejection
Yahoo/AP
Astellas
buyouts
CV Therapeutics
»
Login
or
register
to post comments
News
CV Therapeutics rejects Astellas bid as loss widens
Marketwatch
Astellas
buyouts
CV Therapeutics
earnings
»
Login
or
register
to post comments
News
CV Therapeutics will review Astellas offer again
Forbes
Astellas
buyouts
CV Therapeutics
»
Login
or
register
to post comments
« first
‹ previous
1
2
3
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT